196 related articles for article (PubMed ID: 29582468)
1. Let-7c restores radiosensitivity and chemosensitivity and impairs stemness in oral cancer cells through inhibiting interleukin-8.
Peng CY; Wang TY; Lee SS; Hsieh PL; Liao YW; Tsai LL; Fang CY; Yu CC; Hsieh CS
J Oral Pathol Med; 2018 Jul; 47(6):590-597. PubMed ID: 29582468
[TBL] [Abstract][Full Text] [Related]
2. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
3. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
[TBL] [Abstract][Full Text] [Related]
4. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
5. Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma.
Cui SY; Huang JY; Chen YT; Song HZ; Feng B; Huang GC; Wang R; Chen LB; De W
Mol Cancer Res; 2013 Jul; 11(7):699-713. PubMed ID: 23562878
[TBL] [Abstract][Full Text] [Related]
6. let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma.
Peng J; Mo R; Ma J; Fan J
World J Surg Oncol; 2015 May; 13():175. PubMed ID: 25951903
[TBL] [Abstract][Full Text] [Related]
7. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
[TBL] [Abstract][Full Text] [Related]
8. Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling.
Chang MT; Lee SP; Fang CY; Hsieh PL; Liao YW; Lu MY; Tsai LL; Yu CC; Liu CM
Environ Toxicol; 2018 Nov; 33(11):1105-1112. PubMed ID: 30076764
[TBL] [Abstract][Full Text] [Related]
9. pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells.
Pu Y; Li Q; Wang Y; Xu L; Qiao Q; Guo Y; Guo C
BMC Cancer; 2021 Dec; 21(1):1283. PubMed ID: 34847866
[TBL] [Abstract][Full Text] [Related]
10. Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer.
Chang CJ; Hsu CC; Chang CH; Tsai LL; Chang YC; Lu SW; Yu CH; Huang HS; Wang JJ; Tsai CH; Chou MY; Yu CC; Hu FW
Oncol Rep; 2011 Oct; 26(4):1003-10. PubMed ID: 21725603
[TBL] [Abstract][Full Text] [Related]
11. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
12. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
[TBL] [Abstract][Full Text] [Related]
13. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
Chang YC; Jan CI; Peng CY; Lai YC; Hu FW; Yu CC
Oncotarget; 2015 Sep; 6(27):24002-16. PubMed ID: 26090866
[TBL] [Abstract][Full Text] [Related]
14. Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer.
Han HB; Gu J; Zuo HJ; Chen ZG; Zhao W; Li M; Ji DB; Lu YY; Zhang ZQ
J Pathol; 2012 Feb; 226(3):544-55. PubMed ID: 21984339
[TBL] [Abstract][Full Text] [Related]
15. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
16. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
[TBL] [Abstract][Full Text] [Related]
17. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.
Sugimura K; Miyata H; Tanaka K; Hamano R; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Clin Cancer Res; 2012 Sep; 18(18):5144-53. PubMed ID: 22847808
[TBL] [Abstract][Full Text] [Related]
18. Hsa-let-7c exerts an anti-tumor function by negatively regulating ANP32E in lung adenocarcinoma.
Wang L; Li J; Li Y; Pang LB
Tissue Cell; 2020 Aug; 65():101372. PubMed ID: 32746998
[TBL] [Abstract][Full Text] [Related]
19. Let-7c inhibits NSCLC cell proliferation by targeting HOXA1.
Zhan M; Qu Q; Wang G; Liu YZ; Tan SL; Lou XY; Yu J; Zhou HH
Asian Pac J Cancer Prev; 2013; 14(1):387-92. PubMed ID: 23534758
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
